Biogen Idec Launches $356M Tender Offer For Facet
Biotechnology company Biogen Idec Inc. commenced a tender offer Monday for all shares of Facet Biotech Corp., in a deal potentially worth $356 million....To view the full article, register now.
Already a subscriber? Click here to view full article